Close
Almac
Achema middle east

Drug Research

aTyr Pharma Announces Research Collaboration with Medical University of South Carolina

aTyr Pharma, Inc. , a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, announced that it has entered into a research collaboration with the Medical University of South Carolina (MUSC). Dr....

Intec Pharma Announces New Research Collaboration Agreement with MSD

Intec Pharma Ltd. announces it has entered into a new research collaboration agreement with MSD, the tradename of Merck & Co., Inc., Kenilworth, NJ, USA. Details of the agreement are confidential. "We are very excited to continue to work with...

Thermo Fisher Scientific signs Partnership Agreement with the new Terasaki Innovation Center for Transplant Diagnostic Research

Thermo Fisher Scientific announced it signed a partnership agreement with the newly formed Terasaki Innovation Center (TIC) to facilitate discovery and development of new pathways and tools to diagnose and better manage transplant patients. The mission of the TIC is...

WuXi Biologics and AB2 Bio Announce Collaboration to Accelerate Commercial-Scale Manufacturing of Tadekinig alfa

WuXi Biologics, a global company with leading open-access biologics technology platforms, and AB2 Bio Ltd., a Swiss advanced clinical-stage biotech company developing innovative therapies for the treatment of severe systemic autoinflammatory diseases, announced that they have entered into a...

Schreiner MediPharm Equips Cap-Lock Security Label with RFID Technology

Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, has enhanced its tamper-evident specialty label, Cap-Lock, with a special RFID inlay. Developed to help hospitals expand digitization initiatives, the label-and-cap security concept for...

3P Biopharmaceuticals and SpyBiotech enter into a vaccine contract manufacturing agreement

3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has signed a manufacturing agreement withSpyBiotech, a company with a novel vaccine platform to target infectious diseases, cancer and chronic...

RedHill Biopharma secures expanded manufacturing for COVID-19 therapeutic candidate

RedHill Biopharma, a specialty biopharmaceutical company, has announced collaborations with two specialist pharmaceutical manufacturers in Europe and Canada to ramp-up manufacturing of opaganib, currently in swiftly progressing global Phase II/III and US Phase II studies for severe COVID-19 pneumonia,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »